Alexandre Cochet - Concepedia

Author

Alexandre Cochet

Also Known As

A Cochet, A. Cochet, ALEXANDRE COCHET, Alexandre A. Cochet, Alexandre COCHET, Alexandre Cochet, Cochet, A., Cochet, Alain, Cochet, Alexandre, Marielle Buisson

260

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Centre Georges François Leclerc Université de Bourgogne Centre National de la Recherche Scientifique Laboratoire d’Électronique, Informatique et Image CHU Dijon Bourgogne

About

Alexandre Cochet is an author at Centre Georges François Leclerc specializing in radiology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.1K
2	Engineering	11	11	243
3	Health Sciences	10	10	346
4	Public Health	5	5	242
5	Applied Physics	1	1	13

Alexandre Cochet

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. Michel Toubeau, Claude Touzery, Patrick Arveux, PubMed	2004	183
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy Alina Berriolo-Riedinger, Claude Touzery, Jean‐Marc Riedinger, European Journal of Nuclear Medicine and Molecular Imaging Breast OncologyOncologic ImagingMedicinePathologyBreast Cancer	2007	178
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma Salim Kanoun, Cédric Rossi, Alina Berriolo-Riedinger, European Journal of Nuclear Medicine and Molecular Imaging Tumor BiologyLymphoid NeoplasiaHodgkin LymphomaMedicinePathology	2014	175
In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with <sup>18</sup>F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy Louis Berthet, Alexandre Cochet, Salim Kanoun, Journal of Nuclear Medicine	2013	168
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes Olivier Humbert, Alina Berriolo-Riedinger, Jean‐Marc Riedinger, Annals of Oncology Breast OncologyNeoadjuvant Chemotherapy18F-fdg Tumor MetabolismMedicinePathology	2012	109
Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma Salim Kanoun, Ṭal Ilan, Alina Berriolo-Riedinger, PLoS ONE	2015	107
Emidec: A Database Usable for the Automatic Evaluation of Myocardial Infarction from Delayed-Enhancement Cardiac MRI Alain Lalande, Zhihao Chen, Thomas Decourselle, Data Heart FailureDiagnosisDelayed-enhancement Cardiac MriDiagnostic ImagingMagnetic Resonance Imaging	2020	92
18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations Alexandre Cochet, Inna Dygai‐Cochet, Jean‐Marc Riedinger, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission Tomography18F-fdg Pet/ctBreast OncologyMedical ImagingMedicine	2013	90
HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy Olivier Humbert, Alexandre Cochet, Jean‐Marc Riedinger, European Journal of Nuclear Medicine and Molecular Imaging Breast OncologyMedicinePathologyEarly PredictionBreast Cancer	2014	80
Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction Alexandre Cochet, Luc Lorgis, Alain Lalande, European Radiology Cardiovascular DiseaseMajor Prognostic ImpactMyocardial InfarctionCoronary Artery DiseaseCardiology	2009	73

Page 1